Cargando…
Intrapartum Management of Sickle Cell Anemia With Rare Antibody and Minimal Blood Availability
Sickle cell disease (SCD) can pose serious maternal and fetal risk in pregnancy. Transfusion, both during and outside of pregnancy, can improve patient morbidity and mortality but carries risk of alloimmunization, complicating future management. This case describes a 29-year-old gravida 1, para 0 wo...
Autores principales: | Dom, Aaron M., Pollack, Rebecca, Koklanaris, Nikki, Veeramreddy, Padmaja, Osunkwo, Ifeyinwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383651/ https://www.ncbi.nlm.nih.gov/pubmed/34434389 http://dx.doi.org/10.14740/jmc3479 |
Ejemplares similares
-
Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease
por: Osunkwo, Ifeyinwa, et al.
Publicado: (2020) -
Elevated Circulating Angiogenic Progenitors and White Blood Cells Are Associated with Hypoxia-Inducible Angiogenic Growth Factors in Children with Sickle Cell Disease
por: Ofori-Acquah, Solomon F., et al.
Publicado: (2012) -
Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management
por: Ballas, Samir K., et al.
Publicado: (2012) -
Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high‐ and low‐ to middle‐income countries for the international Sickle Cell World Assessment Survey
por: Osunkwo, Ifeyinwa, et al.
Publicado: (2022) -
Erratum to “Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management”
por: Ballas, Samir K., et al.
Publicado: (2013)